PLA2G6-Associated Neurodegeneration (PLAN): Review of Clinical Phenotypes and Genotypes
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PLA2G6-associated neurodegeneration (PLAN) is a group of rare genetic disorders characterised by progressive neurodegeneration resulting from mutations in the PLA2G6 gene, encoding a calcium-independent phospholipase enzyme.”
From Decanoic acid extends lifespan and modulates metabolism in models of PLA2G6 -associated neurodegeneration (2025) · cites this paper as Guo et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical and genetic delineation of neurodegeneration with brain iron accumulation
Gregory, A., Polster, B. J., & Hayflick, S. J. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.061929 · Cited by 364 · cited 4×
“In most INAD cases, an MRI shows signs of iron accumulation in the globus pallidus and/or the substantia nigra (21).”
BackgroundInfluential
Research works printed but not linked: 95
- Gregory, 2008, Neurodegeneration associated with genetic defects in phospholipase A(2), Neurology, 71, 1402, 10.1212/01.wnl.0000327094.67726.28 · DOI · Paper page
- Kurian, 2008, Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN), Neurology, 70, 1623, 10.1212/01.wnl.0000310986.48286.8e · DOI · Paper page
- Schneider, 2012, Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations, Mov Disord., 27, 42, 10.1002/mds.23971 · DOI · Paper page
- Hayflick, 2018, Neurodegeneration with brain iron accumulation, Handb Clin Neurol, 147, 293, 10.1016/B978-0-444-63233-3.00019-1 · DOI · Paper page
- Khateeb, 2006, PLA2G6 mutation underlies infantile neuroaxonal dystrophy, Am J Hum Genet., 79, 942, 10.1086/508572 · DOI · Paper page
- Paisan-Ruiz, 2010, Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations, Mov Disord., 25, 1791, 10.1002/mds.23221 · DOI · Paper page
- Shi, 2011, PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort, Neurology, 77, 75, 10.1212/WNL.0b013e318221acd3 · DOI
- Gui, 2013, Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease, Parkins Relat Disord., 19, 21, 10.1016/j.parkreldis.2012.07.016 · DOI
- Gregory, 1993, PLA2G6-Associated Neurodegeneration
- Xie, 2015, Homozygous p.D331Y mutation in PLA2G6 in two patients with pure autosomal-recessive early-onset parkinsonism: further evidence of a fourth phenotype of PLA2G6-associated neurodegeneration, Parkinsonism Relat Disord., 21, 420, 10.1016/j.parkreldis.2015.01.012 · doi:10.1016/j.parkreldis.2015.01.012
- Smalheiser, 1998, Calcium-independent phospholipase A2 and schizophrenia, Arch Gen Psychiatry, 55, 752, 10.1001/archpsyc.55.8.752-a · doi:10.1001/archpsyc.55.8.752-a
- Ramanadham, 2003, Pancreatic islets and insulinoma cells express a novel isoform of group VIA phospholipase A2 (iPLA2 beta) that participates in glucose-stimulated insulin secretion and is not produced by alternate splicing of the iPLA2 beta transcript, Biochemistry, 42, 13929, 10.1021/bi034843p · doi:10.1021/bi034843p
- Morgan, 2006, PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron, Nat Genet., 38, 752, 10.1038/ng1826 · DOI · Paper page
- Khan, 2014, Ophthalmic features of PLA2G6-related paediatric neurodegeneration with brain iron accumulation, Br J Ophthalmol., 98, 889, 10.1136/bjophthalmol-2013-304527 · DOI
- Paisan-Ruiz, 2012, Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations, Neurobiol Aging, 33, 814, 10.1016/j.neurobiolaging.2010.05.009 · DOI · Paper page
- Riku, 2013, Extensive aggregation of alpha-synuclein and tau in juvenile-onset neuroaxonal dystrophy: an autopsied individual with a novel mutation in the PLA2G6 gene-splicing site, Acta Neuropathol Commun., 1, 12, 10.1186/2051-5960-1-12 · DOI
- Kapoor, 2016, Genetic Analysis of PLA2G6 in 22 Indian Families with Infantile Neuroaxonal Dystrophy, Atypical Late-Onset Neuroaxonal Dystrophy and Dystonia Parkinsonism Complex, PLoS ONE, 11, e0155605, 10.1371/journal.pone.0155605 · DOI
- Illingworth, 2014, PLA2G6-associated neurodegeneration (PLAN): Further expansion of the clinical, radiological and mutation spectrum associated with infantile and atypical childhood-onset disease, Mol Genet Metab., 112, 183, 10.1016/j.ymgme.2014.03.008 · DOI
- Rohani, 2018, Oculogyric crises in PLA2G6 associated neurodegeneration, Parkins Relat Disord., 52, 111, 10.1016/j.parkreldis.2018.03.010 · doi:10.1016/j.parkreldis.2018.03.010
- Seitelberger, 1971, Neuropathological conditions related to neuroaxonal dystrophy, Acta Neuropathol., 17
- Tonelli, 2010, Novel splice-site mutations and a large intragenic deletion in PLA2G6 associated with a severe and rapidly progressive form of infantile neuroaxonal dystrophy, Clin Genet, 78, 432, 10.1111/j.1399-0004.2010.01417.x · DOI
- Salih, 2013, New findings in a global approach to dissect the whole phenotype of PLA2G6 gene mutations, PLoS ONE, 8, e76831, 10.1371/annotation/cb01a74a-3330-4412-8040-2a94842420ed · DOI
- Darling, 2018, PLA2G6-associated neurodegeneration: new insights into brain abnormalities and disease progression, Parkinsonism Relat Disord, 10.1016/j.parkreldis.2018.10.013 · DOI
- Gitiaux, 2018, PLA2G6-associated neurodegeneration: Lessons from neurophysiological findings, Eur J Paediatr Neurol., 22, 854, 10.1016/j.ejpn.2018.05.005 · DOI
- Nardocci, 1999, Infantile neuroaxonal dystrophy: clinical spectrum and diagnostic criteria, Neurology, 52, 1472, 10.1212/WNL.52.7.1472 · DOI · Paper page
- Crompton, 2010, Multiplex ligation-dependent probe amplification (MLPA) analysis is an effective tool for the detection of novel intragenic PLA2G6 mutations: implications for molecular diagnosis, Mol Genet Metab., 100, 207, 10.1016/j.ymgme.2010.02.009 · DOI
- Davids, 2016, Disruption of Golgi morphology and altered protein glycosylation in PLA2G6-associated neurodegeneration, J Med Genet., 53, 180, 10.1136/jmedgenet-2015-103338 · DOI
- Li, 2016, Monozygotic twins with infantile neuroaxonal dystrophy: A case report and literature review, Exp Ther Med., 12, 3387, 10.3892/etm.2016.3761 · doi:10.3892/etm.2016.3761
- Iannello, 2017, A new PLA2G6 mutation in a family with infantile neuroaxonal dystrophy, J Neurol Sci., 381, 209, 10.1016/j.jns.2017.08.3260 · DOI
- Mascalchi, 2017, Fast progression of cerebellar atrophy in pla2g6-associated infantile neuronal axonal dystrophy, Cerebellum, 16, 742, 10.1007/s12311-017-0843-z · doi:10.1007/s12311-017-0843-z
- Farina, 1999, Infantile neuroaxonal dystrophy: neuroradiological studies in 11 patients, Neuroradiology, 41, 376, 10.1007/s002340050768 · DOI
- Iodice, 2017, Infantile neuroaxonal dystrophy and PLA2G6-associated neurodegeneration: an update for the diagnosis, Brain Dev., 39, 93, 10.1016/j.braindev.2016.08.012 · DOI
- Wu, 2009, Clinical study and PLA2G6 mutation screening analysis in Chinese patients with infantile neuroaxonal dystrophy, Eur J Neurol., 16, 240, 10.1111/j.1468-1331.2008.02397.x · DOI
- Bernardi, 2011, MRI findings in patients with clinical onset consistent with Infantile Neuroaxonal Dystrophy (INAD), literature review, clinical and MRI Follow-up, Neuroradiol J., 24, 202, 10.1177/197140091102400207 · DOI
- Aoun, 2015, Mitochondria: A crossroads for lipid metabolism defect in neurodegeneration with brain iron accumulation diseases, Int J Biochem Cell Biol., 63, 25, 10.1016/j.biocel.2015.01.018 · DOI
- Sadeh, 2009, Neurodegeneration associated with genetic defects in phospholipase A2, Neurology, 73, 819, 10.1212/WNL.0b013e3181b2851b · doi:10.1212/wnl.0b013e3181b2851b
- Paisan-Ruiz, 2009, Characterization of PLA2G6 as a locus for dystonia-parkinsonism, Ann Neurol., 65, 19, 10.1002/ana.21415 · DOI · Paper page
- Karkheiran, 2015, PLA2G6-associated dystonia-parkinsonism: case report and literature review, Tremor Other Hyperkinet Mov., 5, 317, 10.7916/D84Q7T4W · DOI
- Virmani, 2014, Oculogyric crises induced by levodopa in PLA2G6 parkinsonism-dystonia, Parkinsonism Relat Disord., 20, 245, 10.1016/j.parkreldis.2013.10.016 · doi:10.1016/j.parkreldis.2013.10.016
- Kamel, 2018, PLA2G6-related parkinsonism presenting as adolescent behavior, Acta Neurol Belg., 10.1007/s13760-018-1003-z · doi:10.1007/s13760-018-1003-z
- Malaguti, 2015, A novel homozygous PLA2G6 mutation causes dystonia-parkinsonism, Parkinsonism Relat Disord, 21, 337, 10.1016/j.parkreldis.2015.01.001 · doi:10.1016/j.parkreldis.2015.01.001
- Sina, 2009, R632W mutation in PLA2G6 segregates with dystonia-parkinsonism in a consanguineous Iranian family, Eur J Neurol., 16, 101, 10.1111/j.1468-1331.2008.02356.x · DOI
- Giri, 2016, PLA2G6 Mutations Related to Distinct Phenotypes: A New Case with Early-onset Parkinsonism, Tremor Other Hyperkinet Mov., 6, 363, 10.7916/D81G0M12 · doi:10.7916/d81g0m12
- Tomiyama, 2011, PLA2G6 variant in Parkinson's disease, J Hum Genet., 56, 401, 10.1038/jhg.2011.22 · DOI
- Lv, 2012, Association between PLA2G6 gene polymorphisms and Parkinson's disease in the Chinese Han population, Parkinsonism Relat Disord., 18, 641, 10.1016/j.parkreldis.2012.02.015 · doi:10.1016/j.parkreldis.2012.02.015
- Tian, 2012, Analysis of PLA2G6 gene mutation in sporadic early-onset parkinsonism patients from Chinese population, Neurosci Lett., 514, 156, 10.1016/j.neulet.2012.02.078 · DOI
- Ozes, 2017, PLA2G6 mutations associated with a continuous clinical spectrum from neuroaxonal dystrophy to hereditary spastic paraplegia, Clin Genet., 92, 534, 10.1111/cge.13008 · DOI
- Koh, 2018, PLA2G6-associated neurodegeneration presenting as a complicated form of hereditary spastic paraplegia, J Hum Genet, 10.1038/s10038-018-0519-7. · DOI
- Chen, 2018, Novel PLA2G6 mutations and clinical heterogeneity in Chinese cases with phospholipase A2-associated neurodegeneration, Parkinsonism Relat Disord., 49, 88, 10.1016/j.parkreldis.2018.02.010 · doi:10.1016/j.parkreldis.2018.02.010
- Tan, 2010, PLA2G6 mutations and Parkinson's disease, Ann Neurol., 67, 148, 10.1002/ana.21663 · doi:10.1002/ana.21663
- Yoshino, 2010, Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism, Neurology, 75, 1356, 10.1212/WNL.0b013e3181f73649 · DOI · Paper page
- Kauther, 2011, The PLA2G6 gene in early-onset Parkinson's disease, Mov Disord., 26, 2415, 10.1002/mds.23851 · DOI
- Agarwal, 2012, Imaging striatal dopaminergic function in phospholipase A2 group VI-related parkinsonism, Mov Disord., 27, 1698, 10.1002/mds.25160 · doi:10.1002/mds.25160
- Lu, 2012, PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson's disease, Am J Med Genet B Neuropsychiatr Genet., 10.1002/ajmg.b.32012 · doi:10.1002/ajmg.b.32012
- Koroglu, 2013, Recessive truncating NALCN mutation in infantile neuroaxonal dystrophy with facial dysmorphism, J Med Genet., 50, 515, 10.1136/jmedgenet-2013-101634 · DOI · Paper page
- Zhang, 2013, Follow-up study of 25 Chinese children with PLA2G6-associated neurodegeneration, Eur J Neurol., 20, 322, 10.1111/j.1468-1331.2012.03856.x · doi:10.1111/j.1468-1331.2012.03856.x
- Goyal, 2015, Molecular diagnosis of infantile neuro axonal dystrophy by next generation sequencing, Indian J Pediatr., 82, 474, 10.1007/s12098-014-1608-z · doi:10.1007/s12098-014-1608-z
- Al-Maawali, 2016, Validation of the finding of hypertrophy of the clava in infantile neuroaxonal dystrophy/PLA2G6 by biometric analysis, Neuroradiology, 58, 1035, 10.1007/s00234-016-1726-6 · doi:10.1007/s00234-016-1726-6
- Blake, 2016, Child neurology: two sisters with dystonia and regression: PLA2G6-associated neurodegeneration, Neurology, 87, e1, 10.1212/WNL.0000000000002804 · doi:10.1212/wnl.0000000000002804
- Dastsooz, 2017, Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports, BMC Med Genet., 18, 87, 10.1186/s12881-017-0439-y · DOI
- Guo, 2017, Identification of novel compound mutations in pla2g6-associated neurodegeneration patient with characteristic MRI Imaging, Mol Neurobiol., 54, 4636, 10.1007/s12035-016-9991-2 · DOI
- Michelis, 2017, Expanded phenotype and hippocampal involvement in a novel compound heterozygosity of adult PLA2G6 associated neurodegeneration (PARK14), Parkinsonism Relat Disord., 37, 111, 10.1016/j.parkreldis.2017.01.005 · doi:10.1016/j.parkreldis.2017.01.005
- Wirth, 2017, Severe early-onset impulsive compulsive behavior and psychosis in PLA2G6-related juvenile Parkinson's disease, Parkinsonism Relat Disord., 41, 127, 10.1016/j.parkreldis.2017.05.014 · doi:10.1016/j.parkreldis.2017.05.014
- Yamashita, 2017, Mutation screening of PLA2G6 in Japanese patients with early onset dystonia-parkinsonism, J Neural Transm., 124, 431, 10.1007/s00702-016-1658-7 · DOI
- Elsayed, 2018, Case report of a novel homozygous splice site mutation in PLA2G6 gene causing infantile neuroaxonal dystrophy in a Sudanese family, BMC Med Genet., 19, 72, 10.1186/s12881-018-0592-y · DOI
- Ferese, 2018, Heterozygous PLA2G6 mutation leads to iron accumulation within basal ganglia and Parkinson's disease, Front Neurol., 9, 536, 10.3389/fneur.2018.00536 · DOI
- Shen, 2018, Genetic analysis of ATP13A2, PLA2G6 and FBXO7 in a cohort of Chinese patients with early-onset Parkinson's disease, Sci Rep., 8, 14028, 10.1038/s41598-018-32217-4 · DOI
- Wang, 2018, Infantile neuroaxonal dystrophy caused by PLA2G6 gene mutation in a Chinese patient: a case report, Exp Ther Med., 16, 1290, 10.3892/etm.2018.6347 · DOI
- Malley, 2018, The structure of iPLA2beta reveals dimeric active sites and suggests mechanisms of regulation and localization, Nat Commun., 9, 765, 10.1038/s41467-018-03193-0 · DOI · Paper page
- Ma, 1999, Human pancreatic islets express mRNA species encoding two distinct catalytically active isoforms of group VI phospholipase A2 (iPLA2) that arise from an exon-skipping mechanism of alternative splicing of the transcript from the iPLA2 gene on chromosome 22q13.1, J Biol Chem., 274, 9607, 10.1074/jbc.274.14.9607 · DOI
- Hooks, 2008, Role of Ca2+-independent phospholipase A2 in cell growth and signaling, Biochem Pharmacol., 76, 1059, 10.1016/j.bcp.2008.07.044 · DOI
- Ackermann, 1994, Ca(2+)-independent cytosolic phospholipase A2 from macrophage-like P388D1 cells. Isolation and characterization, J Biol Chem., 269, 9227, 10.1016/S0021-9258(17)37098-9 · DOI · Paper page
- Tang, 1997, A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs, J Biol Chem., 272, 8567, 10.1074/jbc.272.13.8567 · DOI · Paper page
- Balsinde, 2005, Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells, Cell Signal., 17, 1052, 10.1016/j.cellsig.2005.03.002 · DOI · Paper page
- Farooqui, 2004, Brain phospholipases A2: a perspective on the history, Prostaglandins Leukot Essent Fatty Acids, 71, 161, 10.1016/j.plefa.2004.03.004 · DOI
- Shirai, 2004, Specific differential expression of phospholipase A2 subtypes in rat cerebellum, J Neurocytol., 33, 297, 10.1023/B:NEUR.0000044191.83858.f7 · doi:10.1023/b:neur.0000044191.83858.f7
- Farooqui, 2006, Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders, Pharmacol Rev., 58, 591, 10.1124/pr.58.3.7 · DOI · Paper page
- Calandria, 2010, Neuroprotectin D1 modulates the induction of pro-inflammatory signaling and promotes retinal pigment epithelial cell survival during oxidative stress, Adv Exp Med Biol., 664, 663, 10.1007/978-1-4419-1399-9_76 · DOI
- Sun, 2018, Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases, Prostaglandins Leukot Essent Fatty Acids, 136, 3, 10.1016/j.plefa.2017.03.006 · DOI · Paper page
- Cámara-Lemarroy, 2010, Molecular inflammatory mediators in peripheral nerve degeneration and regeneration, Neuroimmunomodulation, 17, 314, 10.1159/000292020 · DOI · Paper page
- Broersen, 2018, Structural and aggregation properties of alpha-synuclein linked to phospholipase A2 Action, Protein Pept Lett., 25, 368, 10.2174/0929866525666180326120052 · doi:10.2174/0929866525666180326120052
- Malik, 2008, Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations, Am J Pathol., 172, 406, 10.2353/ajpath.2008.070823 · DOI · Paper page
- Adibhatla, 2010, Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities, Antioxid Redox Signal., 12, 125, 10.1089/ars.2009.2668 · DOI · Paper page
- Kinghorn, 2015, Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction, Brain, 138, 1801, 10.1093/brain/awv132 · DOI · Paper page
- Lin, 2018, Phospholipase PLA2G6, a Parkinsonism-Associated Gene, Affects Vps26 and Vps35, Retromer Function, and Ceramide Levels, Similar to alpha-Synuclein Gain, Cell Metab., 28, 605, 10.1016/j.cmet.2018.05.019 · DOI · Paper page
- Iliadi, 2018, Mutations in the Drosophila homolog of human PLA2G6 give rise to age-dependent loss of psychomotor activity and neurodegeneration, Sci Rep., 8, 2939, 10.1038/s41598-018-21343-8 · DOI · Paper page
- Sanchez, 2018, Pla2g6 deficiency in zebrafish leads to dopaminergic cell death, axonal degeneration, increased beta-synuclein expression, and defects in brain functions and pathways, Mol Neurobiol., 55, 6734, 10.1007/s12035-017-0846-2 · DOI
- Chiu, 2018, PARK14 (D331Y) PLA2G6 causes early-onset degeneration of substantia nigra dopaminergic neurons by inducing mitochondrial dysfunction, ER stress, mitophagy impairment and transcriptional dysregulation in a knockin mouse model, Mol Neurobiol., 10.1007/s12035-018-1118-5. · DOI
- Strokin, 2017, Neurons and astrocytes in an infantile neuroaxonal dystrophy (INAD) mouse model show characteristic alterations in glutamate-induced Ca(2+) signaling, Neurochem Int., 108, 121, 10.1016/j.neuint.2017.03.004 · DOI
- Sun, 2004, Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases, J Lipid Res., 45, 205, 10.1194/jlr.R300016-JLR200 · DOI · Paper page
- Lopez-Vales, 2011, Phospholipase A2 superfamily members play divergent roles after spinal cord injury, FASEB J., 25, 4240, 10.1096/fj.11-183186 · DOI
- Palavicini, 2017, Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A2 in a spatial-specific manner, Acta Neuropathol Commun., 5, 56, 10.1186/s40478-017-0460-6 · DOI
- Engel, 2010, Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism, PLoS ONE, 5, e12897, 10.1371/journal.pone.0012897 · DOI · Paper page
- Klein, 2016, PLA2G6mutations and Parkinsonism: long-term follow-up of clinical features and neuropathology, Mov Disord., 31, 1927, 10.1002/mds.26814 · doi:10.1002/mds.26814
- Rogers, 2013, DHA supplementation: current implications in pregnancy and childhood, Pharmacol Res., 70, 13, 10.1016/j.phrs.2012.12.003 · DOI · Paper page
Cited by
p53 in ferroptosis regulation: The new weapon for the old guardian
Liu, Y., & Gu, W. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00943-y · Cited by 540
Phospholipase iPLA2β averts ferroptosis by eliminating a redox lipid death signal
Sun, W.-Y., Tyurin, V. A., Mikulska-Ruminska, K., Shrivastava, I. H., Anthonymuthu, T. S., Zhai, Y.-J., Pan, M.-H., Gong, H.-B., Lu, D.-H., Sun, J., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-020-00734-x · Cited by 337
Zhang, B., Dunn, E., Williams, R. S. B., Snowden, S., & Augustin, H. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052184
Metadata
- Authors
- Guo, Y.-P., Tang, B.-S., & Guo, J.-F.
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2018-12-18
- Volume
- 9
- ISSN
- 1664-2295
- Cited by
- 104
- References
- 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PLA2G6-Associated Neurodegeneration (PLAN): Review of Clinical Phenotypes and Genotypes. https://app.cochat.ai/papers/10.3389/fneur.2018.01100
- The paper
- Guo, Y.-P., Tang, B.-S., & Guo, J.-F. (2018). PLA2G6-Associated Neurodegeneration (PLAN): Review of Clinical Phenotypes and Genotypes. Frontiers in Neurology. https://doi.org/10.3389/fneur.2018.01100
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.